Literature DB >> 22826342

Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT.

Laurent Descarries1, Mustaph Riad.   

Abstract

Serotonin (5-HT) 5-HT(1A) autoreceptors (5-HT(1A)autoR) and the plasmalemmal 5-HT transporter (SERT) are key elements in the regulation of central 5-HT function and its responsiveness to antidepressant drugs. Previous immuno-electron microscopic studies in rats have demonstrated an internalization of 5-HT(1A)autoR upon acute administration of the selective agonist 8-OH-DPAT or the selective serotonin reuptake inhibitor antidepressant fluoxetine. Interestingly, it was subsequently shown in cats as well as in humans that this internalization is detectable by positron emission tomography (PET) imaging with the 5-HT(1A) radioligand [(18)F]MPPF. Further immunocytochemical studies also revealed that, after chronic fluoxetine treatment, the 5-HT(1A)autoR, although present in normal density on the plasma membrane of 5-HT cell bodies and dendrites, do not internalize when challenged with 8-OH-DPAT. Resensitization requires several weeks after discontinuation of the chronic fluoxetine treatment. In contrast, the SERT internalizes in both the cell bodies and axon terminals of 5-HT neurons after chronic but not acute fluoxetine treatment. Moreover, the total amount of SERT immunoreactivity is then reduced, suggesting that SERT is not only internalized, but also degraded in the course of the treatment. Ongoing and future investigations prompted by these finding are briefly outlined by way of conclusion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22826342      PMCID: PMC3405674          DOI: 10.1098/rstb.2011.0361

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  102 in total

1.  Serotonin transporter antibodies: production, characterization, and localization in the brain.

Authors:  F C Zhou; Y Xu; S Bledsoe; R Lin; M R Kelley
Journal:  Brain Res Mol Brain Res       Date:  1996-12-31

2.  Production of specific anti-rat 5-HT1A receptor antibodies in rabbits injected with a synthetic peptide.

Authors:  S el Mestikawy; M Riad; A M Laporte; D Vergé; G Daval; H Gozlan; M Hamon
Journal:  Neurosci Lett       Date:  1990-10-16       Impact factor: 3.046

3.  Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe.

Authors:  J Dong; C de Montigny; P Blier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1997-09       Impact factor: 3.000

4.  5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls.

Authors:  S Lowther; F De Paermentier; S C Cheetham; M R Crompton; C L Katona; R W Horton
Journal:  J Affect Disord       Date:  1997-02       Impact factor: 4.839

5.  A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism.

Authors:  M Beer; G A Kennett; G Curzon
Journal:  Eur J Pharmacol       Date:  1990-03-20       Impact factor: 4.432

6.  Desensitization of spinal 5-HT1A receptors to 8-OH-DPAT: an in vivo spinal reflex study.

Authors:  P Seth; M Gajendiran; D K Ganguly
Journal:  Neuroreport       Date:  1997-07-28       Impact factor: 1.837

7.  A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain.

Authors:  Daniela Popa; Julie Cerdan; Christelle Repérant; Bruno P Guiard; Jean-Philippe Guilloux; Denis J David; Alain M Gardier
Journal:  Eur J Pharmacol       Date:  2009-11-26       Impact factor: 4.432

8.  Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons.

Authors:  Thorsten Lau; Sandra Horschitz; Stefan Berger; Dusan Bartsch; Patrick Schloss
Journal:  FASEB J       Date:  2008-01-23       Impact factor: 5.191

9.  Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers.

Authors:  Igor Sibon; Chawki Benkelfat; Paul Gravel; Nicolas Aznavour; Nicolas Costes; Shadrek Mzengeza; Linda Booij; Glen Baker; Jean-Paul Soucy; Luc Zimmer; Laurent Descarries
Journal:  Biol Psychiatry       Date:  2008-01-14       Impact factor: 13.382

10.  Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins.

Authors:  Marcelle Moulin-Sallanon; Yves Charnay; Nathalie Ginovart; Pascale Perret; Laurence Lanfumey; Michel Hamon; René Hen; Daniel Fagret; Vicente Ibáñez; Philippe Millet
Journal:  Synapse       Date:  2009-02       Impact factor: 2.562

View more
  29 in total

1.  Serotonin Signaling through Prefrontal Cortex 5-HT1A Receptors during Adolescence Can Determine Baseline Mood-Related Behaviors.

Authors:  Alvaro L Garcia-Garcia; Qingyuan Meng; Sarah Canetta; Alain M Gardier; Bruno P Guiard; Christoph Kellendonk; Alex Dranovsky; E David Leonardo
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

Review 2.  MicroRNAs in neuronal communication.

Authors:  Guilherme Shigueto Vilar Higa; Erica de Sousa; Lais Takata Walter; Erika Reime Kinjo; Rodrigo Ribeiro Resende; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2014-01-03       Impact factor: 5.590

3.  Robust presynaptic serotonin 5-HT(1B) receptor inhibition of the striatonigral output and its sensitization by chronic fluoxetine treatment.

Authors:  Shengyuan Ding; Li Li; Fu-Ming Zhou
Journal:  J Neurophysiol       Date:  2015-03-18       Impact factor: 2.714

4.  Serotonin transporter protein in autopsied brain of chronic users of cocaine.

Authors:  Junchao Tong; Jeffrey H Meyer; Isabelle Boileau; Lee-Cyn Ang; Paul J Fletcher; Yoshiaki Furukawa; Stephen J Kish
Journal:  Psychopharmacology (Berl)       Date:  2020-06-03       Impact factor: 4.530

5.  The neurobiology of depression--revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms.

Authors:  Paul R Albert; Chawki Benkelfat; Laurent Descarries
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

6.  The neurobiology of depression--revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies.

Authors:  Paul R Albert; Chawki Benkelfat
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

7.  Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments.

Authors:  Kristin A Connors; Theodore W Valenti; Kelly Lawless; James Sackerman; Emmanuel S Onaivi; Bryan W Brooks; Georgianna G Gould
Journal:  Aquat Toxicol       Date:  2013-12-12       Impact factor: 4.964

8.  Postpartum Lactation-Mediated Behavioral Outcomes and Drug Responses in a Spontaneous Mouse Model of Obsessive-Compulsive Disorder.

Authors:  Swarup Mitra; McKenzie Mucha; Savanah Owen; Abel Bult-Ito
Journal:  ACS Chem Neurosci       Date:  2017-10-05       Impact factor: 4.418

9.  The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.

Authors:  Jacob P R Jacobsen; Per Plenge; Benjamin D Sachs; Alan L Pehrson; Manuel Cajina; Yunzhi Du; Wendy Roberts; Meghan L Rudder; Prachiti Dalvi; Taylor J Robinson; Sharon P O'Neill; King S Khoo; Connie Sanchez Morillo; Xiaodong Zhang; Marc G Caron
Journal:  Psychopharmacology (Berl)       Date:  2014-05-09       Impact factor: 4.530

Review 10.  Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.

Authors:  Benjamin Adam Samuels; Indira Mendez-David; Charlène Faye; Sylvain André David; Kerri A Pierz; Alain M Gardier; René Hen; Denis J David
Journal:  Neuroscientist       Date:  2014-12-08       Impact factor: 7.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.